Senior Scientific Claims Manager (1 Year Contract) - London - £50-60,000 Senior Scientific Clai[...]

Senior Scientific Claims Manager (1 Year Contract) - London - £50-60,000
Can you effortlessly translate scientific material into simplified language to excite the consumer?Joining this Leading Global Beauty Business as Senior Scientific Claims Manager, you will lead and develop a team of advisors, providing scientific and technical support across a wide international portfolio of innovative cosmetic brands.You are a creative problem solver with a proven track record for product claims. You will review and approve all communication materials for multiple brands, producing the most compelling product claims for packaging and advertising content, whilst also ensuring they meet European, National and Global Regulatory Standards.You will liaise proactively with the UK legal team, international claims and regulatory groups. Using your strong interpersonal skills you will build strong and collaborative relationships with both internal and external stakeholders.If this sounds like the perfect fit for you, get in touch today! (AE1633B)Email your CV to ##### or contact:Heidi Bannister 01183 778 393 / 07747 792 272 / ##### Filipa Calado 07792 958 152 / ##### Bannister 07393 818 620 / ##### years’ experience in a related FMCG role in the cosmetic industry, including strong demonstrated ability in regulatory and scientific affairs.Strong experience in the beauty care/dermatology area.Minimum honours degree in one of the life sciences particularly, pharmacology, chemistry, biology or biochemistry or cosmetic science.
X
LinkedIn
You may also like
Drug Delivery Aptar Digital Health and Gerresheimer collaborate to develop integrated solution for subcutaneous cancer therapy
Manufacturing XBiotech to begin constructing new R&D facility on its 48 acre campus
Research & Development Recursion adds new chemical entity targeting fibrotic diseases to late discovery pipeline
Finance AGI Group acquires Chemtrix BV to expand into the large-scale flow chemistry market
Research & Development Boehringer Ingelheim licenses multiple Dark Antigens from Enara Bio to develop immunotherapies for NSCLC
Finance ADC Therapeutics regains compliance with NYSE continued listing standards
Regulatory PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 to treat cognitive impairment
Subscribe now
#J-18808-Ljbffr